Press Releases

SAN DIEGO, Aug. 7, 2019 /PRNewswire/ -- Regen BioPharma Inc. (OTCQB: RGBP) and (OTCQB: RGBPP),  announced today filing of a US patent application covering a newly discovered synergy between inhibition of NR2F6 and cannabidiol (CBD). The new data demonstrates enhanced ability to reduce cancer growth in an efficacious manner while appearing not to induce any form of

BAUDETTE, Minn., Aug. 7, 2019 /PRNewswire/ --For the second quarter 2019:Net revenues of $54.4 million, an increase of 15% versus prior year GAAP net income of $6.6 million and diluted GAAP earnings per share of $0.53, increa

NEW YORK, Aug. 7, 2019 /PRNewswire/ -- StriVectin, the #1 largest independent clinical brand in the U.S. Prestige skin care market, proudly welcomes iconic sup

SAN CARLOS, Calif., Aug. 7, 2019 /PRNewswire/ -- Glycomine, Inc., a biotechnology company focused on developing new therapies for rare diseases, today announced that it has raised $33 million in a Series B financing led by Novo Holdings A/S. Proceeds from the financing will be used to advance Glycomine's substrate replacement therapy f

NEW YORK, Aug. 7, 2019 /PRNewswire/ -- Disrupting the natural healthcare industry by injecting a fresh take on preventative care is the name of the game for Family Self Care's

SAINT PAUL, Minn., Aug. 7, 2019 /PRNewswire/ -- The American Academy of Family Physicians (AAFP), American Academy of Pediatrics (AAP), American College Health Association (ACHA), American College of Obstetricians and Gynecologists (ACOG), American Pharmacists Association (APhA), Immunization Action Coalition (IAC), and Society for Adolescent He

NILES, Ill., Aug. 7, 2019 /PRNewswire/ -- Building upon a legacy of creating high-quality, realistic baby dolls since 1985, Ashton-Drake introduces Kayla the Comfort Doll, a doll designed for those living with the effects of Alzheimer's and other forms of dementia. It is a special addition in the company's So Truly Real® Cuddling Comfort li

Strainprint™ Technologies Ltd., Gynica & Lumir Lab to release custom questionnaire to select eligible participants for world-leading medical cannabis research TORONTO, Aug. 7, 2019 /PRNewswire/ -

EMERYVILLE, Calif., Aug. 7, 2019 /PRNewswire/ -- Berkeley Lights, Inc. (BLI), a pioneer and leader in digital cell biology, today announced the appointment of

PHILADELPHIA, Aug. 7, 2019 /PRNewswire/ -- Aevi Genomic Medicine, Inc. (NASDAQ: GNMX, "Aevi") today announced that it has obtained the right to exercise an exclusive global license for MEDI2338, a Phase 2-ready fully human monoclonal antibody (mAb) that targets interleukin 18 (IL-18). The Company plans to initially develop MEDI2338 for adult onset Still's disease (AOSD)